Balyasny Asset Management L.P. Takes Position in Larimar Therapeutics, Inc. (NASDAQ:LRMR)

Balyasny Asset Management L.P. purchased a new position in Larimar Therapeutics, Inc. (NASDAQ:LRMR – Free Report) in the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm purchased 79,496 shares of the company’s stock, valued at approximately $308,000. Balyasny Asset Management L.P. owned about 0.12% of […]

Leave a Reply

Your email address will not be published.

Previous post Fabrinet (NYSE:FN) Holdings Reduced by Balyasny Asset Management L.P.
Next post Light Up the Road: Why H7 LED Headlight Bulbs Are a Game-Changer for Your Vehicle